CAS 73963-62-9

6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]quinolin-2(1H)-one

Description:

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]quinolin-2(1H)-one, with the CAS number 73963-62-9, is a chemical compound that belongs to the class of quinoline derivatives. This substance features a quinolinone core, which is characterized by a fused bicyclic structure containing a nitrogen atom. The presence of a butoxy group and a cyclohexyl-substituted tetrazole moiety contributes to its unique properties, potentially influencing its solubility, biological activity, and interaction with various biological targets. Quinoline derivatives are often studied for their pharmacological properties, including antimicrobial, anti-inflammatory, and anticancer activities. The tetrazole ring is known for its ability to form strong hydrogen bonds and may enhance the compound's binding affinity to specific receptors or enzymes. Overall, the structural complexity of this compound suggests potential applications in medicinal chemistry, particularly in drug development, although specific biological activities and mechanisms would require further investigation through experimental studies.

Formula: C₂₀H₂₅N₅O₂

InChI: InChI=1/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26)

SMILES: C1CCC(CC1)n1c(CCCCOc2ccc3c(ccc(=O)[nH]3)c2)nnn1

Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)

CAS: 73963-62-9

Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof

Formula: C₂₀H₂₅N₅O₂

Color and Shape: White Brown Powder

Molecular weight: 367.20083

Ref: 45-1134175

Cilostazol USP Related Compound B (Cilostazol Metabolite (OPC-13015))

CAS: 73963-62-9

Formula: C₂₀H₂₅N₅O₂

Color and Shape: White To Off-White Solid

Molecular weight: 367.45

Ref: 4Z-C-076

3,4-Dehydro Cilostazol

CAS: 73963-62-9

3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol used for pharmacokinetic studies. Cilostazol is a selective PDE3A inhibitor.

Formula: C₂₀H₂₅N₅O₂

Purity: 98.89%

Color and Shape: Solid

Molecular weight: 367.44

Ref: TM-T38135

3,4-Dehydrocilostazol (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)

Controlled Product

CAS: 73963-62-9

Formula: C₂₀H₂₅N₅O₂

Color and Shape: Neat

Molecular weight: 367.44

Ref: 86-MM0796.01

Cilostazol USP Related Compound B-d11 (Cilostazol Metabolite (OPC-13015)-d11)

CAS: 73963-62-9

Formula: C₂₀H₁₄D₁₁N₅O₂

Molecular weight: 378.52

Ref: 4Z-C-0710

3,4-Dehydro Cilostazol

Controlled Product

CAS: 73963-62-9

Impurity Cilostazol USP Related Compound B
Applications A metabolite of Cilostazol.

Formula: C₂₀H₂₅N₅O₂

Color and Shape: Off White

Molecular weight: 367.44

Ref: TR-D229500

Cilostazol USP Related Compound B

CAS: 73963-62-9

Formula: C₂₀H₂₅N₅O₂

Molecular weight: 367.44

Ref: ST-EA-CP-C6002

3,4-Dehydro cilostazol

CAS: 73963-62-9

3,4-Dehydro cilostazol is a selective inhibitor of cyclic nucleotide phosphodiesterase III (PDEIII). It has been shown to be effective in cases of hepatic impairment, and its pharmacokinetic properties have been studied in human liver. 3,4-Dehydro cilostazol has shown to increase the concentration of cyclic adenosine monophosphate (cAMP) levels in plasma and urine samples. 3,4-Dehydro cilostazol may cause drug interactions with other drugs that are substrates for PDEIII or that have an effect on the metabolism of endogenous substances.

Formula: C₂₀H₂₅N₅O₂

Purity: Min. 95%

Molecular weight: 367.45 g/mol

Ref: 3D-FD20902